VRTX : Vertex Pharmaceuticals Incorporated stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-06-06 |
|---|---|---|---|---|
| 2023 | $338.47 | $328.6 | $352.16 | 2.44% |
| 2024 | $456.01 | $359.47 | $555.37 | 38.01% |
| 2025 | $624.28 | $564.69 | $671.56 | 88.94% |
| 2026 | $559.31 | $476.46 | $654.08 | 69.28% |
| 2027 | $428.18 | $393.3 | $464.9 | 29.59% |
| 2028 | $277.15 | $189.04 | $382.0 | -16.12% |
| 2029 | $164.35 | $140.32 | $184.31 | -50.26% |
| 2030 | $99.61 | $72.84 | $134.2 | -69.85% |
| 2031 | $63.28 | $53.46 | $70.93 | -80.85% |
| 2032 | $41.83 | $37.09 | $51.02 | -87.34% |
| 2033 | $33.73 | $30.04 | $36.6 | -89.79% |
The 26 Wall Street analysts offering Vertex Pharmaceuticals Incorporated stock forecast in the last 6 months have average price target of
$348.77 with a high forecast of $456.0 and a low forecast of $285.0.
The average Vertex Pharmaceuticals Incorporated stock forecast represents a 5.56%
increase from the last price of $330.410003662109.
From AI system, total return is 2366.52% from 4098 forecasts.
For Vertex Pharmaceuticals Incorporated stock forecast for 2023, 6 predictions are offered for each month of 2023 with average Vertex Pharmaceuticals Incorporated stock
forecast of $338.47, a high forecast of $352.16, and a low forecast of $328.6.
The average Vertex Pharmaceuticals Incorporated stock forecast 2023 represents a 2.44%
increase from the last price of $330.410003662109.
For Vertex Pharmaceuticals Incorporated stock forecast for 2024, 12 predictions are offered for each month of 2024 with average Vertex Pharmaceuticals Incorporated stock
forecast of $456.01, a high forecast of $555.37, and a low forecast of $359.47.
The average Vertex Pharmaceuticals Incorporated stock forecast 2024 represents a 38.01%
increase from the last price of $330.410003662109.
For Vertex Pharmaceuticals Incorporated stock forecast for 2026, 12 predictions are offered for each month of 2026 with average Vertex Pharmaceuticals Incorporated stock
forecast of $559.31, a high forecast of $654.08, and a low forecast of $476.46.
The average Vertex Pharmaceuticals Incorporated stock forecast 2026 represents a 69.28%
increase from the last price of $330.410003662109.
For Vertex Pharmaceuticals Incorporated stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average Vertex Pharmaceuticals Incorporated stock
forecast of $277.15, a high forecast of $382.0, and a low forecast of $189.04.
The average Vertex Pharmaceuticals Incorporated stock forecast 2028 represents a -16.12%
decrease from the last price of $330.410003662109.
For Vertex Pharmaceuticals Incorporated stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Vertex Pharmaceuticals Incorporated stock
forecast of $63.28, a high forecast of $70.93, and a low forecast of $53.46.
The average Vertex Pharmaceuticals Incorporated stock forecast 2031 represents a -80.85%
decrease from the last price of $330.410003662109.
For Vertex Pharmaceuticals Incorporated stock forecast for 2033 (10 year), 6 predictions are offered for each month of 2033 with average Vertex Pharmaceuticals Incorporated stock
forecast of $33.73, a high forecast of $36.6, and a low forecast of $30.04.
The average Vertex Pharmaceuticals Incorporated stock forecast 2033 represents a -89.79%
decrease from the last price of $330.410003662109.
Please, see more forecasts below.
VRTX : Vertex Pharmaceuticals Incorporated stock forecast by Wall Street Analysts
The average Vertex Pharmaceuticals Incorporated stock forecast from last 6 month is $348.77, and this show a 11.69% increase in average from the prior price target of the each prediction. Also, this average forecast of $348.77 represents a 14.05% increase from the past average forecast of $305.8, 6 months ago from 15 wall street analysts.
Vertex Pharmaceuticals Incorporated stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-06-08 | $340.50 | 3.05% |
| 2023-06-09 | $347.16 | 1.96% |
| 2023-06-12 | $348.56 | 0.40% |
| 2023-06-13 | $354.38 | 1.67% |
| 2023-06-14 | $353.53 | -0.24% |
VRTX : Long term Vertex Pharmaceuticals Incorporated stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Jul. is $328.60 , for 2024 Jun. is $442.04 , for 2027 Jun. is $430.47 , for 2028 Jun. is $282.59 , for 2032 Jun. is $40.80 , and for 2033 Jun. is $30.04.
VRTX : Vertex Pharmaceuticals Incorporated stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Jul. | $328.60 | -0.55% |
| 2023 Aug. | $330.09 | 0.45% |
| 2023 Sep. | $334.28 | 1.27% |
| 2023 Oct. | $339.88 | 1.68% |
| 2023 Nov. | $345.77 | 1.73% |
| 2023 Dec. | $352.16 | 1.85% |
VRTX : Vertex Pharmaceuticals Incorporated stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $359.47 | 2.08% |
| 2024 Feb. | $368.54 | 2.52% |
| 2024 Mar. | $381.92 | 3.63% |
| 2024 Apr. | $399.94 | 4.72% |
| 2024 May. | $420.34 | 5.10% |
| 2024 Jun. | $442.04 | 5.16% |
| 2024 Jul. | $467.22 | 5.70% |
| 2024 Aug. | $491.30 | 5.15% |
| 2024 Sep. | $512.41 | 4.30% |
| 2024 Oct. | $529.69 | 3.37% |
| 2024 Nov. | $543.88 | 2.68% |
| 2024 Dec. | $555.37 | 2.11% |
VRTX : Vertex Pharmaceuticals Incorporated stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $564.69 | 1.68% |
| 2025 Feb. | $572.39 | 1.36% |
| 2025 Mar. | $579.46 | 1.23% |
| 2025 Apr. | $586.42 | 1.20% |
| 2025 May. | $595.36 | 1.53% |
| 2025 Jun. | $613.30 | 3.01% |
| 2025 Jul. | $644.55 | 5.10% |
| 2025 Aug. | $665.26 | 3.21% |
| 2025 Sep. | $671.56 | 0.95% |
| 2025 Oct. | $669.44 | -0.32% |
| 2025 Nov. | $666.57 | -0.43% |
| 2025 Dec. | $662.29 | -0.64% |
VRTX : Vertex Pharmaceuticals Incorporated stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $654.08 | -1.24% |
| 2026 Feb. | $642.88 | -1.71% |
| 2026 Mar. | $627.77 | -2.35% |
| 2026 Apr. | $608.87 | -3.01% |
| 2026 May. | $585.52 | -3.83% |
| 2026 Jun. | $559.17 | -4.50% |
| 2026 Jul. | $536.50 | -4.05% |
| 2026 Aug. | $520.65 | -2.96% |
| 2026 Sep. | $510.73 | -1.91% |
| 2026 Oct. | $500.45 | -2.01% |
| 2026 Nov. | $488.63 | -2.36% |
| 2026 Dec. | $476.46 | -2.49% |
VRTX : Vertex Pharmaceuticals Incorporated stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $464.90 | -2.43% |
| 2027 Feb. | $454.65 | -2.20% |
| 2027 Mar. | $445.86 | -1.93% |
| 2027 Apr. | $439.36 | -1.46% |
| 2027 May. | $434.39 | -1.13% |
| 2027 Jun. | $430.47 | -0.90% |
| 2027 Jul. | $426.61 | -0.90% |
| 2027 Aug. | $421.24 | -1.26% |
| 2027 Sep. | $415.62 | -1.33% |
| 2027 Oct. | $409.51 | -1.47% |
| 2027 Nov. | $402.31 | -1.76% |
| 2027 Dec. | $393.30 | -2.24% |
VRTX : Vertex Pharmaceuticals Incorporated stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $382.00 | -2.87% |
| 2028 Feb. | $368.22 | -3.61% |
| 2028 Mar. | $351.31 | -4.59% |
| 2028 Apr. | $330.54 | -5.91% |
| 2028 May. | $307.09 | -7.09% |
| 2028 Jun. | $282.59 | -7.98% |
| 2028 Jul. | $258.66 | -8.47% |
| 2028 Aug. | $236.94 | -8.40% |
| 2028 Sep. | $218.76 | -7.67% |
| 2028 Oct. | $205.01 | -6.28% |
| 2028 Nov. | $195.59 | -4.59% |
| 2028 Dec. | $189.04 | -3.35% |
VRTX : Vertex Pharmaceuticals Incorporated stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $184.31 | -2.51% |
| 2029 Feb. | $180.61 | -2.01% |
| 2029 Mar. | $177.45 | -1.75% |
| 2029 Apr. | $174.48 | -1.67% |
| 2029 May. | $171.40 | -1.76% |
| 2029 Jun. | $167.94 | -2.02% |
| 2029 Jul. | $164.06 | -2.31% |
| 2029 Aug. | $159.99 | -2.48% |
| 2029 Sep. | $155.40 | -2.87% |
| 2029 Oct. | $150.57 | -3.11% |
| 2029 Nov. | $145.69 | -3.24% |
| 2029 Dec. | $140.32 | -3.69% |
VRTX : Vertex Pharmaceuticals Incorporated stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $134.20 | -4.36% |
| 2030 Feb. | $127.53 | -4.97% |
| 2030 Mar. | $120.64 | -5.40% |
| 2030 Apr. | $113.75 | -5.71% |
| 2030 May. | $106.97 | -5.96% |
| 2030 Jun. | $100.35 | -6.19% |
| 2030 Jul. | $94.00 | -6.33% |
| 2030 Aug. | $88.12 | -6.26% |
| 2030 Sep. | $82.94 | -5.88% |
| 2030 Oct. | $78.66 | -5.16% |
| 2030 Nov. | $75.34 | -4.22% |
| 2030 Dec. | $72.84 | -3.32% |
VRTX : Vertex Pharmaceuticals Incorporated stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $70.93 | -2.64% |
| 2031 Feb. | $69.40 | -2.14% |
| 2031 Mar. | $68.14 | -1.81% |
| 2031 Apr. | $67.03 | -1.64% |
| 2031 May. | $65.94 | -1.62% |
| 2031 Jun. | $64.79 | -1.75% |
| 2031 Jul. | $63.49 | -2.01% |
| 2031 Aug. | $61.96 | -2.40% |
| 2031 Sep. | $60.18 | -2.88% |
| 2031 Oct. | $58.13 | -3.40% |
| 2031 Nov. | $55.87 | -3.90% |
| 2031 Dec. | $53.46 | -4.31% |
VRTX : Vertex Pharmaceuticals Incorporated stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $51.02 | -4.57% |
| 2032 Feb. | $48.65 | -4.64% |
| 2032 Mar. | $46.42 | -4.58% |
| 2032 Apr. | $44.32 | -4.53% |
| 2032 May. | $42.41 | -4.31% |
| 2032 Jun. | $40.80 | -3.80% |
| 2032 Jul. | $39.53 | -3.09% |
| 2032 Aug. | $38.64 | -2.27% |
| 2032 Sep. | $38.05 | -1.53% |
| 2032 Oct. | $37.68 | -0.97% |
| 2032 Nov. | $37.41 | -0.72% |
| 2032 Dec. | $37.09 | -0.85% |
VRTX : Vertex Pharmaceuticals Incorporated stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $36.60 | -1.32% |
| 2033 Feb. | $35.84 | -2.07% |
| 2033 Mar. | $34.76 | -3.01% |
| 2033 Apr. | $33.38 | -3.97% |
| 2033 May. | $31.77 | -4.83% |
| 2033 Jun. | $30.04 | -5.46% |
Frequently Asked Questions about Vertex Pharmaceuticals Incorporated stock forecast
Is Vertex Pharmaceuticals Incorporated a good long term stock?
From Vertex Pharmaceuticals Incorporated stock forecast , Vertex Pharmaceuticals Incorporated (VRTX) stock cannot be a good investment choice. According to Tudal, the Vertex Pharmaceuticals Incorporated stock price forecast for 2023 Jul. is $328.60013391244 From Vertex Pharmaceuticals Incorporated stock forecast , Vertex Pharmaceuticals Incorporated (VRTX) stock can be a good investment choice. According to Tudal, the Vertex Pharmaceuticals Incorporated stock price forecast for 2024 Jun. is $442.038926358891 From Vertex Pharmaceuticals Incorporated stock forecast , Vertex Pharmaceuticals Incorporated (VRTX) stock can be a good investment choice. According to Tudal, the Vertex Pharmaceuticals Incorporated stock price forecast for 2027 Jun. is $430.465294768486 From Vertex Pharmaceuticals Incorporated stock forecast , Vertex Pharmaceuticals Incorporated (VRTX) stock cannot be a good investment choice. According to Tudal, the Vertex Pharmaceuticals Incorporated stock price forecast for 2028 Jun. is $282.593108254026 From Vertex Pharmaceuticals Incorporated stock forecast , Vertex Pharmaceuticals Incorporated (VRTX) stock cannot be a good investment choice. According to Tudal, the Vertex Pharmaceuticals Incorporated stock price forecast for 2032 Jun. is $40.7950163886589 From Vertex Pharmaceuticals Incorporated stock forecast , Vertex Pharmaceuticals Incorporated (VRTX) stock cannot be a good investment choice. According to Tudal, the Vertex Pharmaceuticals Incorporated stock price forecast for 2033 Jun. is $30.0380078266891
Is Vertex Pharmaceuticals Incorporated stock overvalued?
Vertex Pharmaceuticals Incorporated (VRTX) stock is expected to go UP . Therefore, Tudal would say that Vertex Pharmaceuticals Incorporated (VRTX) stock is NOT overvalued.
Will Vertex Pharmaceuticals Incorporated stock price go up?
Yes. The Vertex Pharmaceuticals Incorporated stock price forecast for 2024 Jun. is $442.038926358891
Is Vertex Pharmaceuticals Incorporated stock a good buy now?
Since closing price on 2023-06-06 is $330.410003662109 and forecast for 2024 Jun. is $442.04, Vertex Pharmaceuticals Incorporated stock is a good 1 year investment.